Drug maker Allchem Lifescience has filed preliminary papers with markets regulator Sebi seeking its approval to raise funds through an initial public offering (IPO). The Gujarat-based company’s proposed IPO comprises fresh issue of equity shares aggregating up to Rs 190 crore and an offer for sale (OFS) of 71.55 lakh equity shares by promoters, according to the draft red herring prospectus (DRHP).
Stocks to buy today: GAIL, Dixon Technologies among top 4 trading ideas for 20 May 2025
Indian market anticipates a positive trading session on Tuesday. This is due to encouraging global signals. Nifty futures saw a dip on Monday. Volatility increased